Assessment of behavioral dependence with the Glover-Nilsson test in smoking cessation treatment;Evaluación de la dependencia psicológica mediante el test de Glover-Nilsson en el tratamiento del tabaquismo

Archivos de Bronconeumologia

Volumn 41, Issue 9, 2005, Pages 493-498

  Nerin I ^a   Crucelaegui, A ^a   Novella, P ^a   Beamonte, A ^b   Sobradiel, N ^a   Bernal, V ^a   Gargallo, P ^b  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Glover Nilsson test; Nicotine addiction; Smoking; Smoking cessation

Indexed keywords

NICOTINE;

ABSTINENCE; ADDICTION; ADULT; ARTICLE; BEHAVIOR; CIGARETTE SMOKING; FEMALE; GLOVER NILSSON TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SCORING SYSTEM; SEX DIFFERENCE; SMOKING CESSATION; TOBACCO DEPENDENCE;

EID: 26844468885     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13078651     Document Type: Article

References (30)

1. US Department of Health and Human Services. The health consequences of smoking: nicotine addiction: a report from the Surgeon General. Washington DC: Government Printing Office, 1988. DHHS Publication n.° (CDC) 88-8406.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: APA; 1994.
3. Rodríguez de Fonseca F, Navarro M. Role of the limbic system in dependence on drugs. Ann Med. 1998;30:397-405.
4. Micó JA, Moreno Brea MR, Roca Vinardell A, Rojas Corrales MO, Ortega Alvaro A. Neurobiología de la adicción a la nicotina. Prev Tab. 2000;2:101-5.
5. Benowitz NL. Nicotine addiction. Prim Care. 1999;26:611-31.
6. Ramos Pinedo A. Diagnóstico clínico del tabaquismo. En: SEPAR, editor. Manual de Tabaquismo SEPAR. Barcelona: Ediciones Masson; 2002. p. 127-40.
7. Picciotto MR. Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci. 2003;24:493-9.
8. Fagerström K, Schneider N. Measuring nicotine dependence a review of the Fagerström tolerance questionnaire. J Behav Med. 1989;12:159-82.
9. Ling Tang J, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ. 1994;308:21-6.
10. West R. Assessment of dependence and motivation to stop smoking. BMJ. 2004;328:338-9.
11. Shiffman S, Dresler CM, Hajek P, Gilburt SJA, Targett DA, Strahs KR. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med. 2002;162:1267-76.
12. Herrera N, Franco R, Herrera L, Partidas A, Rolando R, Fagerström KO. Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest. 1995;108:447-51.
13. Dijkstra A, Tromp D. Is the FTND a measure of physical as well as psychological tobacco dependence? J Subst Abuse Treat. 2002; 23:367-74.
14. Kenford SL, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB. Predicting relapse back to smoking: contrasting affective and physical models of dependence. J Consult Clin Psicol. 2002;70: 216-27.
15. Solano Reina S, Garciá-Tenorio Damasceno A, De Granda JI. Iniciación y mantenimiento del hábito tabáquico. El paciente que va a dejar de fumar. En: Barrueco M, Hernández Mezquita M, Torrecilla M, editores. Manual de prevención y tratamiento del tabaquismo. Madrid: ERGON; 2003. p. 107-40.
16. Nerín I, Crucelaegui A, Mas A, Guillén D. Perfil de los fumadores que solicitan tratamiento en una unidad de tabaquismo. Arch Bronconeumol. 2003;30:298-302.
17. Jarvis M, Russell MAH, Salojee Y. Expired air carbon monoxide. A simple breath test for tobacco smoke intake. Br Med J. 1980; 281:484-5.
18. Glover ED, Nilsson F, Westin A. The Glover-Nilsson Smoking Behavioral Questionnaire (GN-SBQ). Actas de Third European Conference of the Society for Research on Nicotine and Tobacco; 2001, septiembre; París, p. 48.
19. West Virginia University. Disponible en: www.hsc.wvu.edu/som/ bmed/apmr/facultystaff.htm
20. Fagerström KO, Kunze M, Schoberberger R, Breslau N, Hughes JR, Hurt RD, et al. Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control. 1996;5:52-6.
21. Pormeleau OF. Nicotine and the central nervous system: biobehavioral effects of cigarette smoking. Am J Med. 1992;128:221-6.
22. Benowitz NL. Pharmacology of nicotine: addiction and therapeutics. Ann Rev Pharmacol Toxicol. 1996;36:597-13.
23. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science. 1997;278:58-3.
24. Becoña E, Vázquez F. Dejar de fumar como un proceso: implicaciones asistenciales. En: Comité Nacional para la Prevención del Tabaquismo (CNPT), editor. Libro blanco sobre el tabaquismo en España. Barcelona: Glosa S.L.; 1998. p. 227-52.
25. Carlson LE, Taenzer P, Koopmans J, Casebeer A. Predictive value of aspects of the transtheorical model on smoking cessation in a community-based, large-group cognitive behavioral program. Addict Behav. 2003;28:725-40.
26. Ramón JM, Bou R, Alkiza ME, Romea S, Oromí J, Saltó E, et al. Proceso de cambio y sexo como predictores del abandono del consumo de tabaco. Arch Bronconeumol. 1999;35:488-93.
27. Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior. Nicotine Tob Res. 2003;5:111-6.
28. Carrión Valero F, Hernández Llopis J, Plaza Valía P. Tabaquismo en sanitarios. Identificación de factores asociados. Arch Bronconeumol. 1998;34:379-83.
29. Monsó E, Campbell J, Tonnensen P, Gustavsson G, Morera J. Sociodemographic predictors of success in smoking intervention. Tob Control. 2001;10:165-9.
30. Becoña E, Vázquez F. Tratamiento del tabaquismo. Madrid: Dykinson; 1998.